Inventor · disambiguated record
Markus Stoffel
Also filed as: STOFFEL MARKUS
19 granted patents·6 pending applications·266 citations·filing 1992–2021
95Inventor score
Top patents by PatentIndex Score
25 records- 0196US7585969B2MicroRNA and methods for inhibiting sameUNIV ROCKEFELLER·Filed 2008·Granted Sep 8, 2009·42 cites·34 claims
- 0295US8541385B2Chemically modified oligonucleotides for use in modulation micro RNA and uses thereofSTOFFEL MARKUS·Filed 2010·Granted Sep 24, 2013·22 cites·12 claims
- 0395US8324366B2Compositions and methods for delivering RNAI using lipoproteinsAKINC AKIN·Filed 2009·Granted Dec 4, 2012·33 cites·18 claims
- 0495US7365058B2MicroRNA and methods for inhibiting sameUNIV ROCKEFELLER·Filed 2004·Granted Apr 29, 2008·82 cites·33 claims
- 0592US8148344B2Compositions and methods for mediating RNAi in vivoAKINC AKIN·Filed 2009·Granted Apr 3, 2012·26 cites·25 claims
- 0688US8877730B2Targeting microRNAs for metabolic disordersETH ZUERICH·Filed 2013·Granted Nov 4, 2014·8 cites·21 claims
- 0786US9243249B2Targeting MicroRNAs for metabolic disordersETH ZUERICH·Filed 2014·Granted Jan 26, 2016·6 cites·20 claims
- 0886US8592388B2Targeting MicroRNAs for metabolic disordersSTOFFEL MARKUS·Filed 2010·Granted Nov 26, 2013·8 cites·20 claims
- 0976US9932595B2Targeting microRNAs for metabolic disordersETH ZUERICH·Filed 2016·Granted Apr 3, 2018·1 cites·15 claims
- 1075US11207342B2High density lipoprotein binding protein (Hdlbp/Vigilin) iRNA compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Dec 28, 2021·1 cites·25 claims
- 1174US9550996B2Targeting microRNAs for metabolic disordersETH ZUERICH·Filed 2015·Granted Jan 24, 2017·1 cites·15 claims
- 1271US9200290B2MicroRNA and methods for inhibiting sameUNIV ROCKEFELLER·Filed 2014·Granted Dec 1, 2015·0 cites·26 claims
- 1371US8088914B2MicroRNA and methods for inhibiting sameSTOFFEL MARKUS·Filed 2009·Granted Jan 3, 2012·0 cites·35 claims
- 1467US8697859B2MicroRNA and methods for inhibiting sameUNIV ROCKEFELLER·Filed 2013·Granted Apr 15, 2014·0 cites·39 claims
- 1566US10287589B2Targeting microRNAs for metabolic disordersETH ZUERICH·Filed 2018·Granted May 14, 2019·0 cites·11 claims
- 1665US9382539B2MicroRNA and methods for inhibiting sameUNIV ROCKEFELLER·Filed 2015·Granted Jul 5, 2016·0 cites·24 claims
- 1764US8383807B2MicroRNA and methods for inhibiting sameUNIV ROCKEFELLER·Filed 2011·Granted Feb 26, 2013·0 cites·36 claims
- 1863US2022202847A1HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOFALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1962US2014073684A1Chemically modified oligonucleotides for use in modulating micro rna and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2061US2007213292A1Chemically modified oligonucleotides for use in modulating micro RNA and uses thereofALNYLAM PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2156US5541060ADetection of glucokinase-linked early-onset non-insulin-dependent diabetes mellitusARCH DEV CORP·Filed 1992·Granted Jul 30, 1996·29 cites·15 claims
- 2251US2007166710A1Methods for inhibiting adipogenesis and for treating type 2 diabetesSTOFFEL MARKUS·Filed 2004·Application pending·0 cites
- 2346US2007123482A1Chemically modified oligonucleotides for use in modulating micro RNA and uses thereofSTOFFEL MARKUS·Filed 2006·Application pending·0 cites
- 2443US2010119489A1Stimulation of Pancreatic Beta Cell ProliferationSTOFFEL MARKUS·Filed 2006·Application pending·0 cites
- 2536US6830886B1Supports for the parallel identification and transcription profiling of polynucleic acidsMEMOREC BIOTEC GMBH·Filed 1999·Granted Dec 14, 2004·7 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Markus Stoffel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →